NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $385,846 | +0.9% | 3,788 | 0.0% | 0.16% | -2.4% |
| Q2 2023 | $382,247 | +9.7% | 3,788 | 0.0% | 0.16% | 0.0% |
| Q1 2023 | $348,496 | +1.4% | 3,788 | 0.0% | 0.16% | +0.6% |
| Q4 2022 | $343,647 | +19.3% | 3,788 | 0.0% | 0.16% | +0.6% |
| Q3 2022 | $288,000 | -41.1% | 3,788 | -34.6% | 0.16% | -39.4% |
| Q2 2022 | $489,000 | -3.7% | 5,788 | 0.0% | 0.27% | +19.0% |
| Q1 2022 | $508,000 | +0.4% | 5,788 | 0.0% | 0.23% | -13.1% |
| Q4 2021 | $506,000 | -10.8% | 5,788 | -3.5% | 0.26% | -23.1% |
| Q4 2020 | $567,000 | -88.2% | 6,000 | -89.4% | 0.34% | -78.6% |
| Q1 2014 | $4,822,000 | -44.4% | 56,713 | -47.4% | 1.58% | -44.6% |
| Q4 2013 | $8,674,000 | +3.7% | 107,916 | -1.0% | 2.84% | -2.9% |
| Q3 2013 | $8,365,000 | +7.5% | 109,043 | -0.9% | 2.93% | +2.1% |
| Q2 2013 | $7,782,000 | – | 110,058 | – | 2.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |